Call for
Breakthrough T1D Grant
About Organisation
Breakthrough T1D, established in 1970 by families affected by type 1 diabetes (T1D), is a nonprofit 501(c)(3) organization dedicated to transforming the future of T1D. Since its inception, the organization has been instrumental in every major advancement in T1D research. Breakthrough T1D is committed to opening doors for individuals living with the condition by driving scientific innovation, shaping policies, and enhancing healthcare access. With a mission to accelerate life-changing breakthroughs for the cure, prevention, and treatment of type 1 diabetes and its complications, Breakthrough T1D supports global collaboration among the brightest minds. By funding cutting-edge research and advocating for patients’ needs, the organization aims to make T1D a thing of the past. As the leading charitable funder of T1D research worldwide, it continues to support scientific exploration through multiple grant mechanisms that foster innovation, discovery, and progress.
About the Grant
Breakthrough T1D offers a variety of grant mechanisms to support transformative research addressing the many challenges of type 1 diabetes. As the world’s leading nonprofit funder of T1D research, the organization provides funding to researchers globally, connecting their work to accelerate the development of effective therapies and potential cures. Three key funding mechanisms are available: Strategic Research Agreements (SRAs), Clinical SRAs, and Innovative Grants. SRAs support research targeting critical scientific gaps. Clinical SRAs focus on clinical trials and patient-oriented studies, aiming to develop new treatments and monitoring tools. Innovative Grants provide seed funding for high-risk, high-reward projects that have the potential to shift existing paradigms or lead to groundbreaking discoveries. These funding opportunities aim to attract innovative proposals with a strong focus on mission relevance, scientific significance, and feasibility.
Who can Apply?
Applications are welcome from qualified individuals holding an MD, DMD, DVM, PhD, or equivalent, along with a faculty or equivalent research position. Eligible institutions include domestic and international nonprofit organizations, public and private universities, hospitals, laboratories, and governmental research units. While for-profit organizations are generally not eligible, exceptions are made under special programs for industry-based proposals. All applications must demonstrate a strong alignment with Breakthrough T1D’s mission, scientific merit, and innovation. Proposals should reflect potential for significant progress in curing or managing T1D. Clinical SRAs must adhere to human subject research standards, including proper study design and ethical safeguards. The organization actively encourages applications from women, individuals with disabilities, and underrepresented groups in science, fostering diversity and excellence within its research community.
How to Apply?
Applications must be submitted through the RMS360 portal. Interested researchers should initiate the process by submitting a Letter of Intent (LOI) or responding to an open funding call or direct invitation.
Application Deadline
There is no fixed deadline. Submissions are accepted on a rolling basis based on funding calls and invitations.
Last Date To Apply
Applicants should refer to ongoing or specific project calls within the RMS360 portal for applicable submission timelines.
Grant Amount
Innovative Grants offer up to $200,000 for one year, inclusive of up to 10% indirect costs. Other mechanisms vary in budget and duration based on project needs.
Last Date To Apply
For more information, please visit the grant website here.
